Analysis of constituents of the eastern Nigeria mistletoe, Loranthus micranthus linn revealed presence of new classes of osteogenic compounds

Journal of Ethnopharmacology

Volumn 151, Issue 1, 2014, Pages 643-651

  Omeje, Edwin Ogechukwu ^a,b   Khan, Mohd Parvez ^b   Osadebe, Patience Ogoamaka ^a   Tewari, Deepshikha ^b   Khan, Mohammad Faheem ^c   Dev, Kapil ^c   Maurya, Rakesh ^c   Chattopadhyay, Naibedya ^b  

^a UNIVERSITY OF NIGERIA   (Nigeria)

^b Division of Endocrinology and Center for Research on Anabolic Skeletal Targets in Health and Illness   (India)

^c CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Bone morphogenetic protein 2; Cytotoxicity; Mineralization; Osteoblast differentiation; Osteoporosis

Indexed keywords

3 METHOXY QUERCETIN; 3,4,5 TRIMETHOXY BENZOATE; 7BETA,15ALPHA DIHYDOXY LUPEOL PALMITATE; ALKALINE PHOSPHATASE; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTINEOPLASTIC AGENT; BONE MORPHOGENETIC PROTEIN 2; FRIEDELIN; LUPEOL; METHANOL; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; VISCUM ALBUM EXTRACT;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BARK; BOMBAX; BONE DEVELOPMENT; BONE MINERALIZATION; CALVARIA; CELL DIFFERENTIATION; CELL VIABILITY; CITRUS; COLA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG POTENCY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ESTROGEN ACTIVITY; FEMALE; GARCINIA KOLA; GENE EXPRESSION; IN VITRO STUDY; LORANTHACEAE; LORANTHUS MICRANTHUS; MENOPAUSAL SYNDROME; NEWBORN; NIGERIA; NONHUMAN; OSTEOBLAST; PHYTOCHEMISTRY; PLANT LEAF; PLANT STEM; RAT; TISSUE CULTURE; UPREGULATION; UTERUS; UTERUS WEIGHT; VISCUM ALBUM;

BOMBAX; CITRUS; COLA ACUMINATA; GARCINIA KOLA; LORANTHUS MICRANTHUS; RATTUS;

BONE MORPHOGENETIC PROTEIN-2; CYTOTOXICITY; MINERALIZATION; OSTEOBLAST DIFFERENTIATION; OSTEOPOROSIS;

ANIMALS; FEMALE; LORANTHACEAE; MEDICINE, AFRICAN TRADITIONAL; MISTLETOE; MOLECULAR STRUCTURE; NIGERIA; OSTEOBLASTS; OSTEOGENESIS; PLANT EXTRACTS; PLANT LEAVES; PLANTS, MEDICINAL; RATS; RATS, SPRAGUE-DAWLEY; UTERUS;

EID: 84891481452     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2013.11.029     Document Type: Article

References (35)

1. U. Baumert, I. Golan, M. Redlich, J.J. Aknin, and D. Muessig Cleidocranial dysplasia: molecular genetic analysis and phenotypic-based description of a Middle European patient group Am. J. Med. Genet. A 139A 2 2005 78 85
2. B. Bhargavan, A.K. Gautam, D. Singh, A. Kumar, S. Chaurasia, and A.M. Tyagi Methoxylated isoflavones, cajanin and isoformononetin, have non-estrogenic bone forming effect via differential mitogen activated protein kinase (MAPK) signaling J. Cell Biochem. 108 2009 388 399
3. B. Bhargavan, D. Singh, A.K. Gautam, J.S. Mishra, A. Kumar, A. Goel, M. Dixit, R. Pandey, L. Manickavasagam, S.D. Dwivedi, B. Chakravarti, G.K. Jain, R. Ramachandran, R. Maurya, A. Trivedi, N. Chattopadhyay, and S. Sanyal Medicarpin, a legume phytoalexin, stimulates osteoblast differentiation and promotes peak bone mass achievement in rats: evidence for estrogen receptor β-mediated osteogenic action of medicarpin J. Nutr. Biochem. 23 1 2012 27 38
4. M.F. Delaney Strategies for the prevention and treatment of osteoporosis during early postmenopause Am. J. Obstet. Gynecol. 194 2 2006 S12 S23
5. M. Gass, and B. Dawson-Hughes Preventing osteoporosis-related fractures: an overview Am. J. Med. 119 4 Suppl 1 2006 S3 S11
6. L.C. Gerstenfeld, and T.A. Einhorn Developmental aspects of fracture healing and the use of pharmacological agents to alter healing J. Musculoskel. Neuron Interact. 3 4 2003 297 303
7. A. Gianoukakis, and T.J. Smith The role of cytokines in the pathogenesis of endocrine disease Can. J. Diabet. 28 1 2004 30 42
8. P.S. Jain, and S.B. Bari Isolation of lupeol, stigmasterol and campesterol from petroleum ether extract of woody stem of Wrightia tinctoria Asian J. Plant Sci. 9 2010 163 167
9. P. Johannes, K. Roland, P. Martin, and S. Helmut Changes in proinflammatory cytokine activity after menopause Endocr. Rev. 23 1 2002 90 119
10. M.R. John, M. Arai, D.A. Rubin, K.B. Jonsson, and H. Jüppner Identification and characterization of the murine and human gene encoding the tuberoinfundibular peptide of 39 residues Endocrinology 143 3 2002 1047 1057
11. C.J. Kane, J.H. Meena, and Y.C. Yeh Methyl-3, 4, 5-trihydroxybenzoate is a potent and highly specific inhibitor of herpes simplex virus in vitro. Purification and characterization of methyl gallates from Sapium sebiferum Biosci. Rep. 8 1 1988 85 94
12. A.M. Kaunitz, M.R. Mcclung, and R.G. Feldman Post menopausal osteoporosis: fracture risk and prevention J. Fam. Pract. 58 S1-S6 2009 11
13. K. Khan, K. Sharan, G. Swamkar, B. Chakravarti, T.K. Barbhuyan, S.P. China, M.P. Khan, G.K. Naga, D. Yadav, P. Dixit, M. Rakesh, and C. Naibedya Positive skeletal effects of cladrin, a naturally occurring dimethoxydaidzein, in osteopenic rats that were maintained after treatment discontinuation Osteoporos. Int. 24 4 2013 1455 1470
14. K.C. Kregel, and H.J. Zhang An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations Am. J. Physiol. Regul. Integr. Comp. Physiol. 292 2006 R18 R36 10.1152/ajpregu. 00327.2006
15. A.S.A. Kumar, A.K. Gautam, D. Chandra, D. Singh, B. Changkija, M.P. Singh, and R. Trivedi Identification of kaempferol-regulated proteins in rat calvarial osteoblasts during mineralization by proteomics Proteomics 10 2010 1730 1739
16. S.C. Laws, Carey, J.M. Ferrell, G.J. Bodman, and R.L. Cooper Estrogenic activity of octylphenol, nonylphenol, biphenyl A and methoxychlor in rats Toxicol. Sci. 54 2000 154 167
17. P. Mattabhor, Z. Zhouran, B. Heidi, R. Hernan, T. Renny, and A. Franceschi BMP Signaling Is Required for RUNX2-Dependent Induction of the Osteoblast Phenotype J. Bone Miner. Res. 2006 21 2006 637 646
18. S.B. Mahato, and A.P. Kundu 13C NMR Spectra of pentacyclic triterpenoids-a compilation and some salient features Phytochemistry 37 1994 1517 1575
19. M.E. Nadia, A.S. Nazrun, M. Norazlina, N.M. Isa, M. Norliza, and N. Ima The anti-inflammatory, phytoestrogenic, and antioxidative role of Labisia pumila in prevention of postmenopausal osteoporosis Adv. Pharm. Sci. 2012 2012 10.1155/2012/706905
20. E.O. Omeje, P.O. Osadebe, C.O. Esimone, K. Akira, and P. Proksch Three hydroxylated Lupeol-based triterpenoid esters isolated from Eastern Nigeria Mistletoe parasitic on Kola acuminata Nat. Prod. Res. 2011 2011 10.1080/14786419.2011.603316
21. E.O. Omeje, P.O. Osadebe, C.S. Nworu, K. Akira, and P. Proksch Immunomodulatory activity of a lupane triterpenoid ester isolated from the Eastern Nigeria mistletoe, Loranthus micranthus (Linn) Asian Pacific J. Trop. Med., 2011 4 2 2011 412 420
22. E.O. Omeje, P.O. Osadebe, k. Akira, D. Abdessamad, C.O. Esimone, S.C. Nworu, and P. Proksch Steroids and triterpenoids and steroids from the leaves of the Eastern Nigeria mistletoe with immunomodulatory potentials Phytochem. Lett. 2011 10.1016/j.phytol.2011.07.011
23. E.O. Omeje, P.O. Osadebe, K. Akira, C.O. Esimone, P. Proksch, and N.J. Nwodo A novel sesquiterpene acid and an alkaloid from leaves of the Eastern Nigeria mistletoe with potent immunostimulatory activity on C57BL6 splenocytes Pharm. Biol. 2011 10.3109/13880209.2011.621129 (2011)
24. P.O. Osadebe, and E.O. Omeje Comparative toxicities and immunomodulatory potentials of five Eastern Nigeria mistletoes J. Ethnopharmacol. 126 2009 287 293
25. A.L. Ososki, and E.J. Kennelly Phytoestrogens: a review of the present state of research Phytother. Res. 17 845-869 2003 2003
26. S. Patel, and S. Panda Emerging roles of mistletoes in malignancy management 3 Biotech. 2013 10.1007/s/3205-0170124-6
27. N.M. Saarinen, C. Bingham, S. Lorenzetti, A. Mortensen, A. Mäkelä, P. Penttinem, I.K. Sørensen, L.M. Valsta, F. Virgili, G. Vollmer, I.A. Wärri, and O. Zierau Tools to evaluate estrogenic potency of dietary phytoestrogens: A consensus paper from The EU thematic network "Phytohealth" (QLKI-2002-2453) Genes Nutr. 1 2006 143 158
28. Y.K. Seo, S. Sebastian, L. Jun, W.D. Gregory, C. Chun-Lan, G. Katie, and H.S. Daniel Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis Arthritis Res. Ther. 12 4 2010 R154
29. K.D. Setchell, X. Zhao, P. Jha, J.E. Heubi, and N.M. Brown The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers Am. J. Clin. Nutr. 90 2009 1029 1037
30. A.J. Tashjian Jr, and R.F. Gagel Teriparatide [human PTH (1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis J. Bone Miner. Res. 21 2006 354 365
31. R. Trivedi, A. Kumar, V. Gupta, S. Kumar, G.K. Nagar, and J.R. Romero et al. Effects of Egb 761 on bone mineral density, bone microstructure, and osteoblast function: possible roles of quercetin and kaempferol Mol. Cell Endocrinol. 302 2009 86 91
32. R. Trivedi, S. Kumar, A. Kumar, J.A. Siddiqui, G. Swarnkar, and V. Gupta et al. Kaempferol has osteogenic effect in ovariectomized adult Sprague-Dawley rats Mol. Cell Endocrinol. 289 2008 85 93
33. R. Trivedi, A. Mithal, and N. Chattopadhyay Anabolics in osteoporosis: the emerging therapeutic tool Curr. Mol. Med. 10 2010 14 28
34. N. Yamamoto, K. Furuya, and K. Hanada Progressive development of the osteoblast phenotype during differentiation of osteoprogenitor cells derived from fetal rat calvaria: model for in vitro bone formation Biol. Pharm. Bull. 25 2002 509 515
35. H. Yoo, S.H. Kim, J. Lee, H.J. Kim, S.H. Seo, B.Y. Chung, C. Jin, and Y.S. Lee Synthesis and antioxidant activity of 3-methoxyflavones Bull. Korean Chem. Soc. 26 12 2005 2057 2060